Highlander Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-42
| Closed | – | – | 628 |
|
2020
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 619 |
|
2020
Q3 | $0 | Buy |
+42
| New | – | ﹤0.01% | 614 |
|
2020
Q2 | – | Sell |
-42
| Closed | – | – | 622 |
|
2020
Q1 | $0 | Buy |
+42
| New | – | ﹤0.01% | 645 |
|
2019
Q3 | – | Sell |
-42
| Closed | – | – | 676 |
|
2019
Q2 | $0 | Hold |
42
| – | – | ﹤0.01% | 701 |
|
2019
Q1 | $0 | Buy |
+42
| New | – | ﹤0.01% | 711 |
|
2018
Q4 | – | Sell |
-42
| Closed | – | – | 718 |
|
2018
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 747 |
|
2018
Q2 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 735 |
|
2018
Q1 | – | Sell |
-42
| Closed | – | – | 774 |
|
2017
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 750 |
|
2017
Q3 | $1K | Hold |
42
| – | – | ﹤0.01% | 727 |
|
2017
Q2 | $1K | Hold |
42
| – | – | ﹤0.01% | 735 |
|
2017
Q1 | $1K | Hold |
42
| – | – | ﹤0.01% | 748 |
|
2016
Q4 | $1K | Hold |
42
| – | – | ﹤0.01% | 749 |
|
2016
Q3 | $1K | Hold |
42
| – | – | ﹤0.01% | 755 |
|
2016
Q2 | $1K | Hold |
42
| – | – | ﹤0.01% | 762 |
|
2016
Q1 | $1K | Hold |
42
| – | – | ﹤0.01% | 776 |
|
2015
Q4 | $1K | Hold |
42
| – | – | ﹤0.01% | 816 |
|
2015
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 846 |
|
2015
Q2 | $0 | Buy |
+42
| New | – | ﹤0.01% | 854 |
|
2015
Q1 | – | Sell |
-43
| Closed | – | – | 851 |
|
2014
Q4 | $0 | Hold |
43
| – | – | ﹤0.01% | 861 |
|
2014
Q3 | $423 | Hold |
43
| – | – | ﹤0.01% | 831 |
|
2014
Q2 | $483 | Hold |
43
| – | – | ﹤0.01% | 801 |
|
2014
Q1 | $519 | Hold |
43
| – | – | ﹤0.01% | 819 |
|
2013
Q4 | $540 | Hold |
43
| – | – | ﹤0.01% | 811 |
|
2013
Q3 | $714 | Hold |
43
| – | – | ﹤0.01% | 812 |
|
2013
Q2 | $651 | Buy |
+43
| New | +$651 | ﹤0.01% | 794 |
|